Carisma Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q2 2024

Taxonomy & unit: us-gaap: shares
Description: Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary: Carisma Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q2 2024.
Carisma Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 41.5M shares, a 3.17% increase year-over-year.

Common Stock, Shares, Outstanding, Quarterly (shares)

Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	41.5M	+1.28M	+3.17%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	41.5M	+1.29M	+3.2%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	40.6M	+38.4M	+1731%	Dec 31, 2023	10-Q	2024-08-08
Q3 2023	40.3M	-162M	-80.1%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	40.3M	-159M	-79.8%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	40.3M	-159M	-79.8%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	2.22M	-197M	-98.9%	Dec 31, 2022	10-K	2024-04-01
Q3 2022	203M	+3.29M	+1.65%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	199M	+11M	+5.84%	Jun 30, 2022	10-Q/A	2022-08-25
Q1 2022	199M	+27.5M	+16%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	199M	+59M	+42%	Dec 31, 2021	10-K	2023-02-28
Q3 2021	199M	+75.8M	+61.3%	Sep 30, 2021	10-Q	2021-11-08
Q2 2021	188M	+71.8M	+61.6%	Jun 30, 2021	10-Q	2021-08-09
Q1 2021	172M	+62M	+56.4%	Mar 31, 2021	10-Q	2021-05-10
Q4 2020	140M	+33.6M	+31.5%	Dec 31, 2020	10-K	2022-02-28
Q3 2020	124M	+22.4M	+22.1%	Sep 30, 2020	10-Q	2020-11-09
Q2 2020	117M	+15.4M	+15.2%	Jun 30, 2020	10-Q	2020-08-10
Q1 2020	110M	+32.5M	+42%	Mar 31, 2020	10-Q	2020-05-11
Q4 2019	107M	+29.3M	+37.9%	Dec 31, 2019	10-K	2021-03-15
Q3 2019	101M	+24.2M	+31.4%	Sep 30, 2019	10-Q	2019-11-12
Q2 2019	101M	+24.3M	+31.5%	Jun 30, 2019	10-Q	2019-08-08
Q1 2019	77.5M	+34.4M	+79.7%	Mar 31, 2019	10-Q	2019-05-10
Q4 2018	77.5M	+42.8M	+123%	Dec 31, 2018	10-K	2020-03-16
Q3 2018	77.1M	+52.4M	+212%	Sep 30, 2018	10-Q	2018-11-09
Q2 2018	77M	-24.6B		Jun 30, 2018	10-Q	2018-08-14
Q1 2018	43.1M	+18.4M	+74.6%	Mar 31, 2018	10-Q	2018-05-15
Q4 2017	34.7M	+10.2M	+41.5%	Dec 31, 2017	10-K	2019-03-01
Q3 2017	24.7M	+543K	+2.25%	Sep 30, 2017	10-Q	2017-11-17
Q2 2017	24.7B^*	+24.7B		Jun 30, 2017	10-Q	2017-08-14
Q1 2017	24.7M	+4.92M	+24.9%	Mar 31, 2017	10-Q	2017-05-04
Q4 2016	24.5M	+4.91M	+25%	Dec 31, 2016	10-K	2018-04-02
Q3 2016	24.2M	+4.62M	+23.6%	Sep 30, 2016	10-Q	2016-11-14
Q2 2016	20M	+698K	+3.61%	Jun 30, 2016	10-Q	2016-08-12
Q1 2016	19.8M	+1.75M	+9.73%	Mar 31, 2016	10-Q	2016-05-05
Q4 2015	19.6M	+1.69M	+9.4%	Dec 31, 2015	10-K	2017-03-24
Q3 2015	19.5M	+3.4M	+21.1%	Sep 30, 2015	10-Q	2015-11-04
Q2 2015	19.3M	+3.22M	+20%	Jun 30, 2015	10-Q	2015-08-13
Q1 2015	18M	+1.98M	+12.3%	Mar 31, 2015	10-Q	2015-04-30
Q4 2014	17.9M	+16.3M	+996%	Dec 31, 2014	10-K	2016-03-25
Q3 2014	16.1M			Sep 30, 2014	10-Q	2014-11-13
Q2 2014	16.1M			Jun 30, 2014	10-Q	2014-08-13
Q1 2014	16M			Mar 31, 2014	10-Q	2014-05-15
Q4 2013	1.64M			Dec 31, 2013	10-K	2015-03-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.